Longbow leads £1.7m Ambicare funding
Longbow Capital has led a ТЃ1.7m funding round in medical devices firm Ambicare Health.
The Scottish Venture Fund also invested, alongside DC Thomson and private investors.
The new capital will be used to launch the company's lead product Ambulight PDT, a light-emitting sticking plaster for the treatment of cancer.
In early 2008 the company closed a £2.5m funding round with major contributions from Longbow Capital and the Scottish Venture Fund.
Based in St Andrews, Ambicare Health (previously known as Lumicure) is a spinout of Dundee's Ninewells Hospital and St Andrews Univeristy. The company has developed a portfolio of wearable light sources for medical and consumer healthcare applications.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








